DCAL167.18

Dishman Carbogen Amcis Limited

· Pharma & Health
₹ CrorePeersHIKALSOLARAPANACEABIOINDSWFTLABSAIPARENTINDOCOSMSPHARMAWINDLASMcap ₹2,621 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation310.9293.7338.7
+ Interest Income0.0-7.50.0
+ Unrealised FX (Gain) / Loss-6.32.4-61.6
+ Other Non-cash Items-30.218.7-22.4
Changes in Working Capital
+ Inventories-85.2-24.5-122.7
+ Trade Receivables — Current123.5-181.129.2
+ Other Current Assets17.5-2.6-38.8
+ Trade Payables — Current88.1127.6113.4
Cash from Operating Activities
Profit Before Tax (per I/S)-122.319.3104.915.0
+ Total Adjustments (incl. Working Capital)418.2226.8235.9
Cash from Operations (pre-tax)296.0246.1340.8
+ Interest Received — Operating-13.00.0-18.5
+ Interest Paid — Operating-120.0-159.5-174.2
+ Income Taxes Paid19.030.35.0
Cash from Operating Activities384.0375.2491.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)303.3216.8266.0
+ Disp of Fixed Assets0.11.3-0.6
+ Purchase of Investments (Equity / Debt)-149.90.00.0
+ Loans & Advances Repaid0.045.80.1
+ Interest Received — Investing12.12.29.3
+ Other Inflows / (Outflows) — Investing-88.4-24.711.9
Cash from Investing Activities-229.5-192.2-245.3
Cash from Financing Activities
+ Proceeds from Borrowings148.2283.1782.5
+ Repayment of Borrowings29.0204.3375.8
+ Payment of Lease Liabilities42.829.950.0
+ Interest Paid98.6151.0156.1
Cash from Financing Activities-22.2-102.1200.6
Net Changes in Cash (pre-FX)132.380.9446.7
+ Effect of FX Rate Changes on Cash131.8-4.00.0
Net Changes in Cash264.177.0446.7
Closing Cash264.1
Reference Items
EBITDA286.5468.9565.6485.0
EBITDA Margin %10.9517.2919.2916.72
Free Cash Flow (CFO − Capex)80.7158.5225.5225.5
Free Cash Flow to Equity127.0760.9
Free Cash Flow per Basic Share5.1510.1114.3814.38
Price to Free Cash Flow11.63
Cash Flow to Net Income-2.50115.815.04
Cash Paid for Taxes19.030.35.0
Cash Paid for Interest98.6151.0156.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.